Clene Inc.

For the period ended Mar 31, 2026. Filed May 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 14, 2026

CLNN$4.41+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share amounts)

	Three Months Ended March 31,
	2026	2025
Revenue:
Product revenue	$1	$64
Royalty revenue	14	17
Total revenue	15	81
Operating expenses:
Cost of revenue	—	20
Research and development	329	1,481
General and administrative	1,747	2,656
Total operating expenses	2,076	4,157
Loss from operations	(2,061)	(4,076)
Other income (expense), net:
Interest income	47	81
Interest expense	(791)	(608)
Issuance costs for common stock warrant liabilities	(393)	—
Loss on initial issuance of equity	(4,582)	—
Change in fair value of common stock warrant liabilities	(1,060)	2,510
Change in fair value of derivative liabilities	713	1,147
Research and development tax credits and unrestricted grants	36	195
Total other income (expense), net	(6,030)	3,325
Net loss before income taxes	(8,091)	(751)
Income tax expense	—	—
Net loss	$(8,091)	$(751)
Other comprehensive income:
Foreign currency translation adjustments	$44	$15
Total other comprehensive income	44	15
Comprehensive loss	$(8,047)	$(736)
Net loss per share – basic and diluted	$(0.69)	$(0.09)
Weighted average common shares used to compute basic and diluted net loss per share	11,644,214	8,824,673

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.